Towa Pharmaceutical Co., Ltd. (TWAPF)

Towa Pharmaceutical Revenue

In the fiscal year ending March 31, 2025, Towa Pharmaceutical had annual revenue of 259.59B JPY with 13.89% growth. Towa Pharmaceutical had revenue of 65.86B in the quarter ending March 31, 2025, with 10.48% growth.

• Revenue: 259.59B JPY
• Revenue Growth: +13.89%
• P/S Ratio: 0.58
• Revenue / Employee: 56.58M JPY
• Employees: 4,588
• Market Cap: 999.40M USD

Revenue Chart

* This company reports financials in JPY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	259.59B	31.66B	13.89%
Mar 31, 2024	227.93B	19.08B	9.13%
Mar 31, 2023	208.86B	43.24B	26.11%
Mar 31, 2022	165.62B	10.72B	6.92%
Mar 31, 2021	154.90B	44.52B	40.33%